No Stomach for Cancer | Be Strong Hearted

A Network for Gastric Cancer Patients, Survivors and Families

Be Strong Hearted ®

Archive for October, 2008

When courage is the cure

Posted by admin On October - 25 - 2008

By Stephen Smith
Boston Globe
October 2008
Karen

Her mother died from stomach cancer at the age of 52.
Her brother was stricken with the same disease at 56.
Bad luck or bad genes, Karen Chelcun Schreiber wondered.

A blood test gave her the answer:

She carried an inherited gene that made it likely that someday she, too, would develop a form of cancer that moves with devastating stealth and speed.

So Schreiber, a 50-year-old from Madison, Wis., traveled to Boston last month to have her stomach removed - in the name of prevention - a life-altering measure taken without hesitation by a woman whose determination was forged in the crucible of loss.

She almost certainly is not the last in her family to endure the surgery, the best hope for stopping a rare cancer sewn into her clan’s genes. One of her other brothers has tested positive, too. And one of her sons. And a niece and a nephew, and, perhaps, other relatives yet to be screened. Read the rest of this entry »

Families, Genetics, News

Hereditary Diffuse Gastric Cancer: NZ Research Update October 2008

Posted by Parry Guilford On October - 1 - 2008

Hereditary diffuse gastric cancer: Research update October 2008

Parry Guilford, Bostjan Humar and Helen More; Cancer Genetics Laboratory, University of Otago

The recent focus of the group has been to understand the molecular events that are occurring as HDGC stomach cancers develop and progress. By understanding these events we will be better placed to identify (i) the reasons and triggers that underlie the variable age of onset in HDGC families (ii) which drugs may be effective in treatment and (iii) possible drugs which can be used to prevent cancer development (chemoprevention).

Our research has demonstrated that specific epigenetic changes to the DNA are critical for the initiation of HDGC. Epigenetic changes consist of modifications to the chromosome micro-structure that prevent genes being normally active. Importantly, these changes differ from mutations in that they are potentially reversible.  We have shown that the 2nd copy of the E-cadherin gene (CDH1) is knocked out in early HDGC cancers by an epigenetic change called DNA methylation.  The combination of the inherited mutation of one copy of the gene and the later methylation (in the stomach) of the second copy results in affected stomach cells having no E-cadherin. We believe this deficit is sufficient to trigger the start of the cancers.  We don’t yet know what is causing the methylation; it may be something preventable (eg perhaps triggered by inflammation) or it may simply be a necessary consequence of normal gastric function.  Regardless, the clear role of epigenetic changes in cancer initiation suggests that drugs which can reverse or prevent the changes may be useful in the chemoprevention of gastric cancer.

As a result, a major focus of our future HDGC research will be to identify and test drugs which can inhibit or reverse the epigenetic inactivation of CDH1. The long-term goal would be to identify a drug or drugs that can be used in combination with gastroscopic surveillance in the management of HDGC families. The first objectives in this research programme will be to develop the necessary techniques to measure epigenetic changes in gastric biopsy samples and then to systematically characterise the changes induced by selected epigenetic drugs to gain confidence that they will be useful in cancer prevention without causing limiting side effects. If these steps progress well over the next couple of years, we would progress to testing the drug(s) in formal clinical trials.

Front, HDGC, Hereditary Diffuse Gastric Cancer, Research
  • Subscribe to News & Updates

  • Welcome

    Join the Be Strong Hearted Network

    Support one another through individual connections and group participation. Create your own journal/blog to share your story with others.

    Create Account

  • Tag Cloud

  • Archives

  • Who's Online

    There are no users currently online.

  • Members

  • Groups

  • Site Wide Activity

    • J Wielgoszinski updated the “Basic” information on their profile   3 days, 15 hours ago

    • J Wielgoszinski updated the “Cancer Profile” information on their profile   3 days, 15 hours ago

    • J Wielgoszinski updated the “Bio” information on their profile   3 days, 15 hours ago

    • Karen Chelcun Schreiber wrote a new blog post: Scientific Advisory Board   3 days, 21 hours ago

      Scientific Advisory Board members are highly accomplished professionals with medical and/or research background, who provide expert and comprehensive perspectives as well as guidance to No Stomach For Cancer, Inc. with regard to technical, medical, and research related topics. The Board provides knowledge and support that are critical in furthering our Mission.

      Daniel C. Chung, MD
      Massachusetts General [...]

    • Nina healey wrote on the wire of the group Lobular Breast Cancer   1 week, 1 day ago

      I am new to this group. I am actually a cousin of Lorraine Ennis. In March 2007, I was diagnosed with Invasive Lobular Carcinoma in my right breast. I had a mastectomy in March, during which the dr checked the lymph nodes by removing the main node and checked it while I [...]

    • Nina healey joined the group Lobular Breast Cancer   1 week, 1 day ago

    • Gretchen Borzi wrote on the wire of the group Lobular Breast Cancer   3 weeks, 2 days ago

      Lorraine and Cathy, you’re stories are inspiring. I wish you both the best of luck with your surgeries and recovery. Right now, it’s hard for me to imagine being in your shoes, but I will most likely be there at some point. Thanks for sharing.